Tabatha Robinson’s Maryland Bet Meets a Medical Slide

Governor Wes Moore named Tabatha Robinson director of the Maryland Cannabis Administration on Jan. 22, 2025. She left New York’s Office of Cannabis Management, where she ran economic development and served as acting chief equity officer, and started on Feb. 19 as acting director pending Senate confirmation.

The hire was a bet that a New York equity operator could run a Maryland market that had already booked more than $1.1 billion in its first full year of adult-use sales. By January 2026 she was briefing the Senate Finance Committee as director. The scoreboard she brought them was mixed: adult-use receipts were still climbing, medical receipts were not, and most lottery winners from the social-equity round were still waiting on a final license.

Moore Recruited New York’s Equity Operator

Will Tilburg, the first MCA director, left on Dec. 4, 2024, after standing up adult-use sales that began July 1, 2023, under the Cannabis Reform Act Moore signed on May 3, 2023. Tilburg’s last year included a licensing round limited to social equity applicants, with 75% of new licenses going to minority-owned firms, and a first full year of sales that exceeded $1.1 billion.

Moore’s appointment of Tabatha Robinson as director reached for a different kind of operator. She was a corporate lawyer in mergers and a Special Assistant Attorney General for Workers’ Rights in Washington, D.C., with a J.D. and M.B.A. from Harvard and a B.A. from Stanford. In New York she had been the person pushing license math toward people with records.

In Maryland, we are transforming cannabis policy from a cudgel to an instrument for shared prosperity and economic advancement. We are grateful that Tabatha Robinson is lending her expertise, judgment, and vision to this critical work.

Gov. Wes Moore, Jan. 22, 2025, appointment announcement

New York Senate Majority Leader Crystal Peoples-Stokes, who had worked with her at the Office of Cannabis Management, called her “an invaluable and principled partner” and closed with a line Moore’s office put on the release: “Maryland’s gain is our loss.”

Robinson answered in kind. “Maryland’s cannabis industry is a national model and its success is a testament to prioritizing product safety for consumers and promoting social equity market-wide,” she said. Two days later, UFCW Local 400, which represents cannabis workers throughout Maryland, welcomed the pick and tied it to New York’s labor-peace deals, saying a union shop was “the best way to ensure equity for all who work in this emerging industry.”

The Lottery Record She Brought South

The New York numbers Moore’s office put on the appointment were about who got paper, not about who rang a register. During Robinson’s tenure there, the office awarded more than 50% of new cannabis licenses to social equity owners, and more than 90% of operational retailers had prior marijuana convictions. She also ran the first expansion of New York’s medical market since 2015, including a new application system and deal review in both medical and adult-use lanes.

Those figures traveled with her because Maryland had already used a similar story on itself. The 2024 social-equity round was Tilburg’s. Robinson inherited the conversion problem that comes after a lottery: conditional winners still had to find rooms, banks, and local zoning before they could sell a gram.

New York’s later sales boom does not sit on her Maryland ledger. Combined adult-use and medical receipts in New York reached about $1.69 billion in 2025, after she had already moved. The bet in Annapolis was narrower. Could the person who had pushed New York’s license share toward people with records keep Maryland’s already-open market growing without giving back the equity claim?

Adult-Use Sales Rose as Medical Fell

In January 2026 she told the Senate Finance Committee the industry generated $1.17 billion in 2025 sales. Cumulative sales since the adult-use start stood at $2.86 billion. The agency counted 187 operating cannabis businesses and 8,101 cannabis workers, and it estimated $97 million in sales tax.

The split under that headline is the part the appointment release did not have. Adult-use sales rose to $918.29 million in 2025 from $806.77 million in 2024. Medical sales fell to $256.03 million from $334.97 million. The adult-use gain of $111.52 million almost covered the medical drop of $78.94 million, and the net was $32.58 million. Medical customers still spent more per month, $317.01 against $198.70 on the adult-use side, but there were fewer of those tickets.

MARYLAND CANNABIS SALES, 2024-2025

MCA’s own slide called the market maturing, “neither matured nor saturated yet.” Flower still led. Growers were not filling all of their allotted canopy and were not sending all they grew down the chain. The conversion pattern is familiar in states that bolted adult-use onto a medical program: patients walk into the same stores without a card, and the medical line item shrinks even when the building is busy.

That is the first place Moore’s wager meets a number. Robinson was hired as an equity and deals person. The 2025 books asked her to manage a medical program that was losing almost a quarter of its dollars while adult-use stores absorbed the traffic.

Capital and Zoning Stall New Stores

The 2023 law’s licensing round selected 205 applicants and produced 192 conditional licenses. As of the January 2026 briefing, MCA had issued 20 final licenses over the prior 10 months. The first opening from that round came in April 2025. Standard dispensaries were the fastest to open. Robinson told senators she expected 60 or more additional openings through October 2026.

Conditional status lets an applicant build and sit through corporate review. It does not let them take inventory or invoice a sale. Final licenses wait on corporate and facility reviews, local zoning confirmation, and a last inspection. MCA stretched the conditional clock from 18 months to 24 months, then, in rules adopted in 2026, allowed eligible holders to seek two more six-month extensions.

WHY CONDITIONAL LICENSES STALL

• Raising capital: Banks and private lenders still treat a cannabis shop as a hard file, so lottery winners wait on money after they wait on paper.
• Securing property: A license without a lease, or a lease in the wrong zone, does not become a store.
• Local zoning: MCA told senators that confusion among local zoning authorities was still slowing the path from conditional to final.

The operating base she inherited was already a working market, not a greenfield. The January 2026 count ran 23 growers, 27 processors, and 109 dispensaries inside the 187-business total. In 2025, about 30% of cannabis business ownership was held by women and 40% by minority individuals. Those ownership shares are the live equity metric now that the lottery is over and the stores are the test.

If the bet was that a New York licensing specialist would turn conditional paper into open doors, the January 2026 cut was early. Twenty final licenses out of 192 conditional files is a conversion still in motion, and the October 2026 target she gave senators sat on zoning boards and term sheets she does not control.

Chapter 605 Pulled Equity Out of MCA

Robinson’s New York title was acting chief equity officer. Maryland had already built a separate Office of Social Equity inside MCA, charged with partnership grants and the Community Reinvestment and Repair Fund. Chapter 605 of 2025 moved that office to the new Department of Social and Economic Mobility.

The shift took effect Oct. 1, 2025, about seven months after she started. A fiscal 2026 budget amendment moved $8.0 million and seven regular positions. The legislative budget analysis for fiscal 2027 records that the Office of Social Equity left the agency as a completed transfer, with a small deficiency covering the last OSE bills that landed before the move.

MCA still licenses, inspects, and writes rules. The restorative-justice grant shop and the community repair fund now sit in another department. That does not erase the 40% minority ownership share or the 75% minority take in the 2024 license round. It does change what “equity director” means in Linthicum. The person hired for that brief is, on the org chart, a market regulator whose equity office reports somewhere else.

In a year-end note she wrote as director, Robinson said it felt like yesterday that she had stepped into the job and listed medical roundtables, the workforce academy’s first anniversary, and a push to get conditional licensees open. The sentence about equity as a market-wide design was from her first day. The statute moved part of that design off her floor before the year closed.

The Reference Lab and a Smaller Checkbook

The work she can show without a lottery drawing is operational. MCA’s briefing counted 62,700 samples tested in 2025, 41 inspections and investigations, and oversight of four independent labs plus the state’s own reference lab, which the agency calls the first accredited cannabis reference lab in the country. In a May 19, 2026, statement, Robinson said ISO/IEC accreditation showed the lab had “established a quality management system that ensures impartiality, confidentiality, and competence.”

The workforce program launched Sept. 4, 2024, before she arrived, as the first in-house cannabis academy of its kind. By the January 2026 briefing it listed 16 courses, 719 people in the virtual academy, and 448 in the in-person academy, with trainees from age 21 to 76 across Baltimore, Anne Arundel, Prince George’s, Talbot, Howard, Somerset, and Frederick counties. The patient call center logged 14,927 calls in 2025.

MCA AT THE 2026 BUDGET HEARING

• Agency budget: The fiscal 2027 allowance is $29.3 million, down $3.4 million, or 10.5%, from the fiscal 2026 working appropriation.
• Incubator money: General funds for the cannabis incubator were $2 million in fiscal 2025 and $5 million in fiscal 2026, then zero in fiscal 2027.
• Staff holes: As of Dec. 31, 2025, MCA had 6 vacant regular positions, including senior program manager and administrator posts, against 101 regular slots in the working budget.
• Enforcement spend: The fiscal 2027 plan still puts $3.7 million into the Alcohol, Tobacco, and Cannabis Commission contract and $3.0 million into public health education.

Beginning in fiscal 2027 the agency is funded entirely from the Cannabis Regulation and Enforcement Fund, which takes sales tax, licenses, and fees. A thinner checkbook and a lab badge can live in the same year. They ask different things of a director hired to talk about shared prosperity. One is a quality system. The other is whether the incubator and the equity grants still have a home once the special fund has to carry the whole shop.

The September Draft Puts Taxes on Renewals

On Aug. 13, 2026, MCA adopted a first 2026 package, effective Sept. 14, that defined sublingual pouches, set grower labor and corrective-action rules, and let conditional licensees seek those extra six-month extensions. A second draft is now on the table. The agency is taking informal comment through Sept. 30, 2026, on draft regulatory amendments open for comment, with a later 30-day formal window once the text prints in the Maryland Register.

WHAT THE SEPTEMBER DRAFT WOULD DO

• Taxes in arrears: MCA could deny a license renewal if the licensee has unpaid taxes in any jurisdiction, with installment plans and offers in compromise carved out.
• Silent files: A conditional license could be rescinded if the holder fails to answer official MCA mail about that license within 30 days.
• Equity definition: The draft clarifies “social equity applicant,” along with caregiver and green waste, to match current statute.
• Immigration records: The text would bar disclosure of sociological information for immigration enforcement unless a valid warrant is produced.
• Declaratory rulings: Petitions, fees, and dispositions would be written into the cannabis chapter under the State Government Article.

That docket is the live test of the 2025 hire. Denying a renewal over tax debt is a collections tool, not a lottery. Rescinding a quiet conditional file is how an agency clears a backlog of 192 names that have not become stores. Redefining a social equity applicant after the equity office has left the building is how the remaining statute still talks about who the market was built for.

She has already been using the enforcement pen. In December 2025 she signed a consent order that sent Green Leaf Medical, doing business as The Cannabist Company, a $33,000 penalty to the Compassionate Use Fund over labeling and sampling issues. The New York dealmaker is, in the Maryland file, also the person who fines a multi-state operator and sends the check to patients.

Public talk about Robinson herself is thin. Industry calendars booked her onto a cannabis banking stage in Washington on Sept. 9-10, 2026. The argument that actually moves is the one on the comment docket: whether unpaid taxes should block a renewal, and whether a lottery winner who goes quiet for 30 days should lose the slot.

Moore asked her to turn cannabis policy into an instrument for shared prosperity. The 2025 receipts came in at $1.17 billion. Medical sales fell, most of the social-equity round is still conditional, and the equity office is in another department. Comment on the next set of rules closes Sept. 30, 2026.

Disclaimer: This article is news reporting and analysis of Maryland cannabis regulation and is for information only. It is not legal advice, medical advice, or advice about buying, selling, or licensing cannabis, and it is not a recommendation to invest in any cannabis business. Readers who need help with a license, a patient registration, a workplace issue, or a health decision should consult a Maryland-licensed attorney, a certifying clinician, or another qualified professional who can review their facts. Sales figures, license counts, and rule drafts reflect the agency and budget documents cited here and can change as MCA, the General Assembly, or the courts act.